AGM Information • Mar 24, 2011
AGM Information
Open in ViewerOpens in native device viewer
Spectris plc Station Road Egham Surrey TW20 9NP
Tel +44 (0)1784 470470 Fax +44 (0)1784 470848 [email protected] www.spectris.com
If you are in any doubt as to the action you should take, you are recommended to seek your own personal financial advice.
If you have sold or otherwise transferred all your Spectris plc shares, please send this document at once to the purchaser or transferee or to the stockbroker, bank or other agent through whom the transfer was effected for transmission to the purchaser or transferee.
Letter from the Chairman to Ordinary Shareholders
24 March 2011
Notice of Annual General Meeting To be held on 13 May 2011
The annual general meeting of Spectris plc (the "Company") will take place at Station Road, Egham, Surrey TW20 9NP on 13 May 2011 at 11.30 a.m. The notice of annual general meeting (the "AGM Notice") is set out on page 5 of this document.
Each shareholder registered on the register of members of the Company at 6.00 p.m. on 11 May 2011 is entitled to vote on the resolutions numbered 1 to 16 contained in the AGM Notice (the "Resolutions"). If you would like to vote on the Resolutions but cannot come to the annual general meeting, please complete the proxy form sent to you with this document and return it to our registrars as soon as possible and in any event not later than 11.30 a.m. on 11 May 2011.
Resolutions 1 to 13 (inclusive) are proposed as ordinary resolutions. This means that for each of those resolutions to be passed, more than half of the votes cast must be in favour of the resolution. Resolutions 14 to 16 (inclusive) are proposed as special resolutions. This means that for each of those resolutions to be passed, at least three-quarters of the votes cast must be in favour.
Within the ordinary and special business (Resolutions 1 to 16) to be transacted at the annual general meeting of the Company to be held on 13 May 2011 the following items proposed by your Board require further explanation.
The biographical details and other information, as required by the UK Corporate Governance Code (the "Code"), for the Directors of the Company who are proposed to be either elected or re-elected, as set out in Resolutions 4, 5, 6, 7, 8, 9 and 10, can be found on pages 34 and 35 of the annual report and accounts of the Company for the year ended 31 December 2010.
The Code requires the Board to set out the reasons why it believes that the non-executive Directors standing for election or re-election, Peter Chambré, Russell King and John Warren, should be elected or re-elected. Mr Chambré is chairman of Xellia Pharmaceuticals A/S and 7TM Pharma A/S, a non-executive director of BTG plc and an adviser to private equity company 3i plc. Mr Chambré was formerly chief executive officer of Cambridge Antibody Technology Group plc and prior to that was
chief operating officer of Celera Genomics Group and chief executive of Bespak plc. Until October 2009, Mr King was chief strategy officer of Anglo American PLC and between 2006 and 2009 was a non-executive director of Anglo Platinum Limited.
He previously spent over 20 years in senior roles at ICI, gaining worldwide experience in its fertiliser, petrochemical and paint businesses. Mr King is a non-executive director of Aggreko plc. Mr Warren is a former group finance director of WH Smith PLC and United Biscuits Plc and is currently a non-executive director of The Rank Group Plc, Bovis Homes Group PLC and Uniq plc. The experience of these Directors is of benefit to the Board in its deliberations.
Following formal evaluation, the Directors' performance continues to be effective and they continue to demonstrate commitment to their respective roles.
In addition to the ordinary business to be transacted at the annual general meeting, your Board is proposing the following four items of special business.
Under the Companies Act 2006 (the "2006 Act"), the Directors of the Company may generally only allot shares or grant rights over shares if authorised to do so by shareholders. In accordance with the current guidelines issued by the Association of British Insurers (the "ABI"), the Directors confirm their intention to seek an annual renewal of the authority granted at the last annual general meeting which expires on 18 May 2011. The renewed authority is to be limited to shares up to an aggregate nominal amount of £1,932,000 (being just less than one-third of the issued share capital of the Company (excluding treasury shares) on 15 March 2011, being the last practicable date prior to the publication of the AGM Notice. The Company held 9,054,399 shares in treasury at 15 March 2011, (being 7.81 per cent of the issued share capital of the Company (excluding treasury shares) on that date).
The authority conferred by this resolution shall (unless previously revoked, varied or renewed) expire at the end of the Company's 2012 annual general meeting. However, the Company may make an offer or agreement prior to the expiry of this authority which would or might require relevant securities to be allotted after the expiry of this authority and in such a case the Directors will be permitted to allot securities pursuant to such offer or agreement as if this authority had not expired.
Other than in respect of the Company's obligations under its employee share schemes, the Directors have no present intention of issuing any shares under this authority, but they believe it to be in the best interests of the Company that they should continue to have this authority so that such allotments can take place to finance appropriate opportunities that may arise.
Your Directors also generally require additional authority from shareholders to allot shares, grant rights over shares or sell treasury shares where they propose to do so for cash otherwise than to existing shareholders pro rata to their holdings. Circumstances may arise in which it would be in the best interests of the Company for the Directors to have the power to issue a limited number of shares or sell treasury shares for cash otherwise than to existing shareholders, to take advantage of business opportunities as these arise or to manage the Company's capital base more effectively.
Your Board proposes that the authority granted at the last annual general meeting be renewed, in accordance with ABI guidelines, to expire at the end of the Company's 2012 annual general meeting; thereby enabling the Directors to allot ordinary shares and sell treasury shares for cash free of statutory pre-emption rights up to an aggregate nominal amount of £312,500, which is equivalent to just less than 5 per cent of the issued share capital of the Company as at 15 March 2011
(being the last practicable date prior to the publication of the AGM Notice). The Directors confirm their intention that no more than 7.5 per cent of the issued ordinary share capital of the Company shall be allotted or re-sold (in the case of treasury shares) for cash on a non pre-emptive basis during any rolling three-year period.
The power given to the Company at the last annual general meeting to purchase its own shares expires on the date of the forthcoming annual general meeting. Your Directors continue to believe that it is in the best interests of the shareholders that the Company should be able to purchase its own shares in circumstances which, in the opinion of the Directors, should result in an improvement in earnings per share for the remaining shareholders.
Your Directors consider that it would be prudent to be able to act at short notice in making such purchases if it were in the best interests of the Company to do so having regard to other investment opportunities open to the Company. In reaching any decision to purchase ordinary shares, the Directors will take into account the Company's cash resources and capital requirements and the effect of any purchase on gearing levels and on earnings per share.
Any shares purchased under this authority may be cancelled or held as treasury shares. Companies may hold shares repurchased as treasury shares with a view to a possible re-sale at a future date rather than having to cancel them. This would give the Company the ability to re-issue treasury shares quickly and cost-effectively and provide the Company with additional flexibility in management of its capital base. Any transfers of treasury shares for the purposes of the Company's employee share schemes will be made within the recommended ten per cent anti-dilution limit set by the ABI.
Your Directors are seeking the authority to make market purchases of up to 11,593,000 ordinary shares, representing just under 10 per cent of the issued ordinary share capital of the Company (excluding treasury shares) on 15 March 2011 (being the last practicable date prior to the publication of the AGM Notice). The maximum price to be paid for an ordinary share of the Company on any occasion will be 105 per cent of the average of the middle market quotations for ordinary shares of the Company as derived from the London Stock Exchange Daily Official List for the five business days preceding the day on which the purchase is made (exclusive of expenses). The minimum price to be paid for an ordinary share of the Company will be 5p (the nominal value of an ordinary share) (exclusive of expenses).
The authority conferred shall (unless previously revoked, varied or renewed) expire at the end of the Company's 2012 annual general meeting. However, if a contract for the purchase of ordinary shares is concluded before the expiry of this authority but the relevant purchase will or may be executed in whole or in part after the expiry of this authority, the Company is authorised to execute such purchase as if this authority had not expired.
The Company has no warrants outstanding and the total number of options to subscribe for equity shares outstanding on 15 March 2011 was 3,711,890, representing 3.20 per cent of the issued share capital of the Company (excluding treasury shares) on that date. If the full authority to buy back shares were to be used, the said outstanding options would represent 3.56 per cent of the issued share capital of the Company (excluding treasury shares) on that date.
Both the 2006 Act and the articles of association of the Company permit general meetings (other than annual general meetings) of the Company to be held on 14 clear days' notice. However, the Companies (Shareholders' Rights) Regulations 2009 (the "Regulations") require that the notice period for general meetings is 21 days, unless the shareholders agree to a shorter notice period. According to the Regulations, companies may still hold general meetings (other than annual general meetings) on 14 days' notice provided electronic voting is made available to all members and that the preceding annual general meeting has approved the calling of general meetings on a 14 day notice period. Your Directors therefore request authority to hold general meetings in the forthcoming year on 14 days' notice ("Short Notice"), as they believe this gives greater flexibility and the ability for a faster response if an unexpected meeting is required. Such authority will be effective
until the Company's next annual general meeting when it is intended that a similar resolution will be proposed. It is intended that general meetings will not be called on Short Notice as a matter of routine but that Short Notice will be used only when the flexibility of using it is merited by the business of the meeting, the circumstances surrounding that business and where calling a general meeting on Short Notice is in the interests of the shareholders as a whole. Further, the Company will comply with the statutory conditions of electronic voting and prior annual general meeting approval set out above.
Your Directors consider that the above proposals are in the best interests of the Company and its shareholders and unanimously recommend that you vote in favour of all the resolutions set out in the AGM Notice as they intend to do in respect of their own shareholdings.
Yours faithfully
J L M Hughes Chairman
Notice is hereby given that the annual general meeting of Spectris plc (the "Company") will be held at the Company's offices at Station Road, Egham, Surrey TW20 9NP on Friday 13 May 2011 at 11.30 a.m. to consider and, if thought fit, pass the following resolutions:
(ii) otherwise than pursuant to paragraph (i) of this resolution, up to an aggregate nominal amount of £312,500,
and any such authority shall expire at the end of the Company's 2012 annual general meeting (save that the Company may, before the expiry of the power hereby conferred, make any offer or agreement which would or might require equity securities to be allotted or treasury shares to be sold after such expiry and the Directors may allot equity securities pursuant to any such offer or agreement as if the power hereby conferred had not expired).
This power applies in relation to a sale of shares which is an allotment of equity securities by virtue of section 560(2)(b) of the 2006 Act as if in the first paragraph of this resolution the words "pursuant to the authority conferred by Resolution 13" were omitted.
BY ORDER OF THE BOARD
[signature]
R J Stephens FCIS Secretary
Registered Office: Station Road, Egham Surrey TW20 9NP
24 March 2011
In order for a proxy appointment or instruction made using the CREST service to be valid, the appropriate CREST message (a "CREST Proxy Instruction") must be properly authenticated in accordance with the specifications of Euroclear UK and Ireland Limited ("Euroclear") and must contain the information required for such instructions, as described in the CREST Manual. The message, regardless of whether it constitutes the appointment of a proxy or an amendment to the instruction given to a previously appointed proxy must, in order to be valid, be transmitted so as to be received by the issuer's agent (ID RA19) by the latest time(s) for receipt of proxy appointments specified in the AGM Notice. For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp applied to the message by the CREST Applications Host) from which the issuer's agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. After this time any change of instructions to proxies appointed through CREST should be communicated to the appointee through other means.
CREST members and, where applicable, their CREST sponsors or voting service providers should note that Euroclear does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed (a) voting service provider(s), to procure that his CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members and, where applicable, their CREST sponsors or voting service providers are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings. The CREST Manual can be reviewed at www.euroclear.com/CREST
The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in Regulation 35(5)(a) of the Uncertificated Securities Regulations 2001.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.